7-103989356-TGCCGCCGCCGCCGCC-TGCCGCCGCCGCCGCCGCCGCC

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_005045.4(RELN):​c.-6_-1dupGGCGGC variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,394,188 control chromosomes in the GnomAD database, including 122,293 homozygotes. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.52 ( 20330 hom., cov: 0)
Exomes 𝑓: 0.43 ( 101963 hom. )

Consequence

RELN
NM_005045.4 5_prime_UTR

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:5

Conservation

PhyloP100: 2.06

Publications

2 publications found
Variant links:
Genes affected
RELN (HGNC:9957): (reelin) This gene encodes a large secreted extracellular matrix protein thought to control cell-cell interactions critical for cell positioning and neuronal migration during brain development. This protein may be involved in schizophrenia, autism, bipolar disorder, major depression and in migration defects associated with temporal lobe epilepsy. Mutations of this gene are associated with autosomal recessive lissencephaly with cerebellar hypoplasia. Two transcript variants encoding distinct isoforms have been identified for this gene. Other transcript variants have been described but their full length nature has not been determined. [provided by RefSeq, Jul 2008]
RELN Gene-Disease associations (from GenCC):
  • lissencephaly with cerebellar hypoplasia
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Norman-Roberts syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, G2P, PanelApp Australia
  • familial temporal lobe epilepsy 7
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal dominant epilepsy with auditory features
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • ankylosing spondylitis
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant 7-103989356-T-TGCCGCC is Benign according to our data. Variant chr7-103989356-T-TGCCGCC is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 130109.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.723 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RELNNM_005045.4 linkc.-6_-1dupGGCGGC 5_prime_UTR_variant Exon 1 of 65 ENST00000428762.6 NP_005036.2
RELNNM_173054.3 linkc.-6_-1dupGGCGGC 5_prime_UTR_variant Exon 1 of 64 NP_774959.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RELNENST00000428762.6 linkc.-6_-1dupGGCGGC 5_prime_UTR_variant Exon 1 of 65 5 NM_005045.4 ENSP00000392423.1

Frequencies

GnomAD3 genomes
AF:
0.522
AC:
77298
AN:
148096
Hom.:
20328
Cov.:
0
show subpopulations
Gnomad AFR
AF:
0.516
Gnomad AMI
AF:
0.423
Gnomad AMR
AF:
0.541
Gnomad ASJ
AF:
0.490
Gnomad EAS
AF:
0.744
Gnomad SAS
AF:
0.675
Gnomad FIN
AF:
0.502
Gnomad MID
AF:
0.547
Gnomad NFE
AF:
0.501
Gnomad OTH
AF:
0.500
GnomAD2 exomes
AF:
0.147
AC:
9416
AN:
63892
AF XY:
0.156
show subpopulations
Gnomad AFR exome
AF:
0.0576
Gnomad AMR exome
AF:
0.0994
Gnomad ASJ exome
AF:
0.0979
Gnomad EAS exome
AF:
0.284
Gnomad FIN exome
AF:
0.211
Gnomad NFE exome
AF:
0.136
Gnomad OTH exome
AF:
0.148
GnomAD4 exome
AF:
0.428
AC:
533190
AN:
1245994
Hom.:
101963
Cov.:
36
AF XY:
0.429
AC XY:
262976
AN XY:
613244
show subpopulations
African (AFR)
AF:
0.431
AC:
10529
AN:
24454
American (AMR)
AF:
0.278
AC:
5676
AN:
20450
Ashkenazi Jewish (ASJ)
AF:
0.362
AC:
7491
AN:
20696
East Asian (EAS)
AF:
0.634
AC:
17115
AN:
26976
South Asian (SAS)
AF:
0.513
AC:
27905
AN:
54362
European-Finnish (FIN)
AF:
0.393
AC:
14567
AN:
37094
Middle Eastern (MID)
AF:
0.439
AC:
1806
AN:
4118
European-Non Finnish (NFE)
AF:
0.423
AC:
425446
AN:
1006444
Other (OTH)
AF:
0.441
AC:
22655
AN:
51400
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.527
Heterozygous variant carriers
0
10781
21562
32343
43124
53905
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
14068
28136
42204
56272
70340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.522
AC:
77336
AN:
148194
Hom.:
20330
Cov.:
0
AF XY:
0.523
AC XY:
37807
AN XY:
72258
show subpopulations
African (AFR)
AF:
0.516
AC:
20756
AN:
40260
American (AMR)
AF:
0.542
AC:
8148
AN:
15024
Ashkenazi Jewish (ASJ)
AF:
0.490
AC:
1690
AN:
3446
East Asian (EAS)
AF:
0.743
AC:
3489
AN:
4694
South Asian (SAS)
AF:
0.674
AC:
3160
AN:
4688
European-Finnish (FIN)
AF:
0.502
AC:
5040
AN:
10046
Middle Eastern (MID)
AF:
0.565
AC:
157
AN:
278
European-Non Finnish (NFE)
AF:
0.501
AC:
33489
AN:
66812
Other (OTH)
AF:
0.501
AC:
1031
AN:
2058
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1753
3505
5258
7010
8763
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
680
1360
2040
2720
3400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.349
Hom.:
609

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:5
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:1
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2013
Genetic Services Laboratory, University of Chicago
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Norman-Roberts syndrome;C4225327:Familial temporal lobe epilepsy 7 Benign:1
Nov 03, 2021
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Lissencephaly, Recessive Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Norman-Roberts syndrome Benign:1
Nov 07, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
2.1
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs55656324; hg19: chr7-103629803; COSMIC: COSV58986596; API